View Latest Issue
Patients often come into the rheumatology setting as candidates for vaccines. Protecting them from infection via vaccination before they receive immunosuppressive therapy should be a priority, advises Elizabeth Kirchner, CNP.
Patients with active psoriatic arthritis (PsA) continued to show clinical and radiographic benefits from treatment with ustekinumab (Stelara; Janssen Biotech) through week 100 in final results of the PSUMMIT 1 clinical trial.
Women with inflammatory rheumatoid arthritis (RA) who are using oral contraceptives (OCs) or report past use of OCs have improved patient-reported outcomes during the first 2 years after diagnosis.
People with symptomatic knee osteoarthritis (OA) have stable to worsening function over time after imputing missing values and adjusting pre–total knee replacement (TKR) scores according to a longitudinal study of patients from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI).
Optimized analgesia for 6 weeks followed by a 12-week exercise program significantly improved pain and function for patients with knee osteoarthritis (OA), according to a new study.
Children prescribed antibiotics had twice the risk of developing juvenile arthritis as those who did not receive antibiotics, and the more antibiotics children were prescribed, the higher the risk of juvenile arthritis developing, according to a study published in Pediatrics.
Patients with chronic rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA) express common fears and beliefs, according to the results of a novel questionnaire presented at the recent meeting of the European League Against Rheumatism.
In a study presented at the 2015 annual meeting of the European League Against Rheumatology, the 5-year risk for major joint surgery was similar for patients with moderate rheumatoid arthritis (RA) compared with those with persistently high levels of disease activity.
Tofacitinib does not appear to increase the risk for nonmelanoma skin cancer (NMSC), according to a safety review across the entire tofacitinib rheumatoid arthritis (RA) clinical program, which was presented at the 2015 annual meeting of the European League Against Rheumatism.
Expect biosimilars to be adopted into clinical rheumatology practice in the United States before long.
Page 1 of 2
Results 1 - 10 of 18
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology